ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Galapagos

Galapagos (GXE)

22.46
-0.68
( -2.94% )
Updated: 00:20:38
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
22.46
Bid
22.62
Offer
22.66
Volume
2,784
22.22 Day's Range 22.70
21.80 52 Week Range 37.08
Market Cap
Previous Close
23.14
Open
22.66
Last Trade
38
@
22.46
Last Trade Time
22:39:25
Financial Volume
-
VWAP
-
Average Volume (3m)
8,815
Shares Outstanding
65,835,511
Dividend Yield
-
PE Ratio
7.02
Earnings Per Share (EPS)
3.22
Revenue
843.8M
Net Profit
211.7M

About Galapagos

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
Headquarters
Mechelen, Antwerp, Bel
Founded
-
Galapagos is listed in the Coml Physical, Biologcl Resh sector of the Tradegate (DE) with ticker GXE. The last closing price for Galapagos was 23.14 €. Over the last year, Galapagos shares have traded in a share price range of 21.80 € to 37.08 €.

Galapagos currently has 65,835,511 shares in issue. The market capitalisation of Galapagos is 1.52 € billion. Galapagos has a price to earnings ratio (PE ratio) of 7.02.

GXE Latest News

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities Galapagos intends to create a new company with approximately €2.45 billion in cash...

Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference Mechelen, Belgium; January 7, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Company...

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma Data from the ongoing Phase...

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024 New Phase 1/2 data support the potential of our CAR T-cell therapy candidates, GLPG5101 and GLPG5201, in...

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update We are advancing our pipeline and accelerating innovation through focused execution of our Forward, Faster...

Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth

Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth Mechelen, Belgium; October 7, 2024, 07:00 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today announced...

Galapagos receives transparency notification from EcoR1 Capital

Galapagos receives transparency notification from EcoR1 Capital Mechelen, Belgium; 30 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a...

Galapagos receives transparency notification from EcoR1 Capital

Galapagos receives transparency notification from EcoR1 Capital Mechelen, Belgium; 16 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a...

Galapagos receives transparency notification from FMR LLC

Galapagos receives transparency notification from FMR LLC Mechelen, Belgium; 3 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency...

Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma

Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma Mechelen, Belgium; August 23, 2024, 07:00...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.74-3.1896551724123.223.3822.22269523.02697195DE
4-3.12-12.197028928925.5830.9622.22372225.51807283DE
12-2.68-10.660302307125.1430.9622.22881525.18083521DE
26-2.54-10.162530.9621.8951425.07886278DE
52-12.56-35.865219874435.0237.0821.8886226.55792836DE
156-27.34-54.899598393649.866.421.8445127.37169318DE
260-156.49-87.4490081028178.95189.321.8267528.59062497DE

GXE - Frequently Asked Questions (FAQ)

What is the current Galapagos share price?
The current share price of Galapagos is 22.46 €
How many Galapagos shares are in issue?
Galapagos has 65,835,511 shares in issue
What is the market cap of Galapagos?
The market capitalisation of Galapagos is EUR 1.52B
What is the 1 year trading range for Galapagos share price?
Galapagos has traded in the range of 21.80 € to 37.08 € during the past year
What is the PE ratio of Galapagos?
The price to earnings ratio of Galapagos is 7.02
What is the cash to sales ratio of Galapagos?
The cash to sales ratio of Galapagos is 1.76
What is the reporting currency for Galapagos?
Galapagos reports financial results in EUR
What is the latest annual turnover for Galapagos?
The latest annual turnover of Galapagos is EUR 843.8M
What is the latest annual profit for Galapagos?
The latest annual profit of Galapagos is EUR 211.7M
What is the registered address of Galapagos?
The registered address for Galapagos is GENERAAL DE WITTELAAN L11, MECHELEN, ANTWERP, A3 2800
What is the Galapagos website address?
The website address for Galapagos is www.glpg.com
Which industry sector does Galapagos operate in?
Galapagos operates in the COML PHYSICAL, BIOLOGCL RESH sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
HPMHorizon Petroleum Ltd
0.165 €
(41.03%)
228.05k
H7KPeak Minerals Limited
0.009 €
(38.46%)
5k
AAHAhlers AG
0.011 €
(37.50%)
3k
L7C2Windfall Geotek Inc
0.011 €
(29.41%)
1.37k
6IVInventiva
2.695 €
(28.64%)
1.88k
SL5Recharge Resources Ltd
0.0208 €
(-41.24%)
500
YBBCarnavale Resources Ltd
0.002 €
(-33.33%)
75.17k
M000Vertical Aerospace Ltd
6.15 €
(-30.90%)
6.45k
PA8Paion AG
0.0152 €
(-29.63%)
438
K1SNKlondike Silver Corporation
0.007 €
(-26.32%)
1.5k
PF8European Lithium Limited
0.0352 €
(-12.87%)
8.17M
W1HOnco Innovations Limited
1.496 €
(23.64%)
1.41M
D7GNel ASA
0.1878 €
(-1.73%)
1.32M
432Arbor Metals Corp
0.3635 €
(15.76%)
1.2M
HDDHeidelberger Druckmaschinen AG
1.188 €
(4.95%)
964.58k

Discussion

View Full Feed
Natural Trader Natural Trader 42 seconds ago
$SDST 2.18 Breaks Ground on One of The Largest U.S. Battery-Grade Lithium Refineries
SDST
BlazingStocks BlazingStocks 52 seconds ago
$COEP News January 23, 2025

Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation Innovation
https://finance.yahoo.com/news/coeptis-therapeutics-leverages-artificial-intelligence-130900942.html
COEP
#1 PATRIOTS_RSOX FAN #1 PATRIOTS_RSOX FAN 1 minute ago
CBDD due updates 

Audits
Germany
Whats been happening behind the scene. 

Lets go CBDD, throw us a bone
CBDD
Trooperstocks Trooperstocks 1 minute ago
NEWS: Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation Innovation
PR Newswire
Thu, January 23, 2025 at 8:09 AM EST 5 min read


In This Article:
COEP
+13.56%
COEPW
+31.31%
Coeptis Harnesses
COEP
Trooperstocks Trooperstocks 2 minutes ago
$COEP $11.80 +9.26% Pre-market- COEP CEO Dave Mehalick commented, "We are embarking on an exciting journey of expansion that will not only enhance our presence in the biopharma sector but also venture into the high-growth technology sector." https://bit.ly/4gO5w3D
#Tech #AI #Biotech #Scien
COEP
Trooperstocks Trooperstocks 2 minutes ago
$COEP $11.80 +9.26% Pre-market- COEP CEO Dave Mehalick commented, "We are embarking on an exciting journey of expansion that will not only enhance our presence in the biopharma sector but also venture into the high-growth technology sector." https://bit.ly/4gO5w3D
#Tech #AI #Biotech #Scien
COEP
ison929 ison929 2 minutes ago
Ooops... .29??? quite a while since last shown. Over .30 tom, closed
NWBO
nowwhat2 nowwhat2 3 minutes ago
Gee........Uh........Boy.........Uh........Well........Uh.........Duh



https://investorshub.advfn.com/uimage/uploads/2025/1/20/wfumjxrp_!_20_hyper_mag_8pm_inaug.jpg


.
XRPUSD
IronSeer69 IronSeer69 4 minutes ago
EVTL is taking a hit this a.m. Anyone know why?
EVTL
Zardiw Zardiw 4 minutes ago
#DDAmanda Video - $BLBX - Gain: +188% Video Analysis - #1 Stock Screener / Scanner

https://www.youtube.com/watch?v=NWAaIRKxmM0

Z
BLBX
JAB65 JAB65 5 minutes ago
Always on top of things my friend!
Great find/post!!
President Donald Trump’s sweeping Day One energy executive orders also reached into the gears of government to boost the prospects of a single company with a floundering liquefied natural gas project.

The move to smoo
TGLO
Bobbar Bobbar 5 minutes ago
2 weeks!
UATG
Invest-in-America Invest-in-America 5 minutes ago
DGNX: $500-per-share coming today, FOLKS!!! It is DAY-JOY-VOODOO , all over again!!!! (WHO opened this DGNX iHub board ??? ME!!! And WHO opened that legendary @HKD iHub board??? ME!!! What strange FATE is at work here, FOLKS!!!)

https://media0.giphy.com/media/v1.Y2lkPTc5MGI3NjEx
DGNX
PioneerPhoenix73 PioneerPhoenix73 6 minutes ago
SINTX Technologies, Inc. has been hinting at a major restructuring plan, and frankly, it sounds like they're facing a serious uphill battle. They're basically throwing in the towel on their Utah headquarters and moving to Boise to cut costs. It seems like their silicon nitride material just isn't se
SINT
dexprs dexprs 6 minutes ago
What is the 10 am rule in stocks?
AI Overview
The 10 AM rule in stocks is a trading strategy that suggests waiting until 10 AM to make big moves in the stock market. This is because the market is often volatile at the opening, and waiting can help traders avoid the initial volatility.
stocktowatch stocktowatch 6 minutes ago
$ASII LATEST NEWS ! GlobeTopper Achieves $39.5M in 2024 Revenue, Driven by Strong Q4 Performance
NEW YORK - January 22, 2025 (NEWMEDIAWIRE) - Accredited Solutions, Inc. (OTC: ASII) ("Accredited Solutions" or the "Company"), parent company of Diamond Creek, is thrilled to announce that its who
ASII
resx18 resx18 6 minutes ago
Good Morning $CBDW
CBDW
boi568 boi568 6 minutes ago
Some people here pretend to know the SAP. That must count for something.
AVXL
helpx helpx 7 minutes ago
2 weeks
UATG
resx18 resx18 7 minutes ago
Good Morning $CBDL
CBDL
linkvest linkvest 7 minutes ago
You must of gotten a new fill yesterday... RDAR is setting up nicely for a run. Just might get out of the TRIPs this week yet. Maybe today....
RDAR
FDApproved FDApproved 7 minutes ago
Yaky Yanay, Chief Executive Officer and President of Pluri. “We are pleased that Mr. Weinstein understands our mission and will take part in shaping our strategy as we progress. We believe that Mr. Weinstein’s equity investment will strengthen our financial foundation and allow us to advance our ent
PLUR
glenn1919 glenn1919 7 minutes ago
WKSP......PRPL........RR,,,,,,,ALXO...........................https://stockcharts.com/h-sc/ui?s=WKSP&p=D&yr=0&mn=2&dy=12&id=p84071410134
ALXO WKSP
TheDane TheDane 7 minutes ago
I agree. Musk is going to be a problem either in with Trump or out. It looks like high school antics and jealousies could screw things up.
SMCI
ap17 ap17 8 minutes ago
Patience grasshopper........patience, the trash was just taken out on 1-20, just a few more rats left to exterminate and we'll be good.
SHIBUSD

Your Recent History

Delayed Upgrade Clock